news

Tumor molecular biology more significant than race in breast cancer survival

Race did not significantly predict response to treatment outcomes among women with high-risk breast cancer in a new study of nearly 1,000 women. Beverly Kyalwazi, MD, and her colleagues found that tumor biology more strongly predicted a positive outcome from treatment. Black women who received appropriate therapies based on their tumor profiles saw the same […]

Tumor molecular biology more significant than race in breast cancer survival Read More »

Black and Hispanic Women Have Triple Odds for Lymphedema After Breast Cancer Surgery

Black and Hispanic women experience more than three times the risk compared to White women of developing swelling in the arms and legs called lymphedema after breast cancer treatment, according to new research. The study followed 276 women with breast cancer who received a unilateral axillary lymph node dissection, which removes lymph nodes located above,

Black and Hispanic Women Have Triple Odds for Lymphedema After Breast Cancer Surgery Read More »

Young Black women more likely to be infected with HPV than White women in Mississippi

Cervical cancer screening results among women in Mississippi suggests that young Black women have a higher prevalence of infection with human papillomavirus (HPV) at younger ages than do White women. Researchers  studied 6,871 women who underwent cervical cancer screening in Mississippi during 2018. The prevalence of HPV infection was 50.2% among Black participants aged 21

Young Black women more likely to be infected with HPV than White women in Mississippi Read More »

Black women under-represented in social media for breast reconstruction

African American women are less likely to be pictured in social media posts showing the outcomes of breast reconstruction, according to an analysis of 2,580 photos on Instagram, Facebook, Twitter and other social media. While African American women accounted for about 13 percent of patients undergoing post-mastectomy breast reconstruction in 2018, less than 7 percent

Black women under-represented in social media for breast reconstruction Read More »

Black men diagnosed with prostate cancer in California more likely than White men to have high PSA levels

Black men in California were much more likely to have high PSA scores of 20 or more at the time of their diagnosis than White men in the state. Researchers led by David J. Press (above) reviewed the cases of more than 170,000 men diagnosed with prostate cancer in California. Black men who came from

Black men diagnosed with prostate cancer in California more likely than White men to have high PSA levels Read More »

Black males in Tennessee more likely than Whites to delay treatment for prostate cancer

Black males are 32 percent more likely than Whites to delay treatment for prostate cancer in Tennessee. During the years 2005 to 2015 in Tennessee, Blacks as well as divorced or separated men who were diagnosed with prostate cancer were more likely than White or single men to postpone treatment for at least 3 months.

Black males in Tennessee more likely than Whites to delay treatment for prostate cancer Read More »

Cervical cancer rates in NYC highest in poorest neighborhoods

Women living in New York City neighborhoods with the lowest socioeconomic status (SES) had a 73 percent greater chance of being diagnosed with cervical cancer than women living in neighborhoods with the highest SES, according to research. Stephanie Cham, MD (above) of the Dana-Farber Brigham Cancer Center and colleagues analyzed data collected from New York

Cervical cancer rates in NYC highest in poorest neighborhoods Read More »

Blacks and Hispanics under-represented in colorectal cancer trials

Black and Hispanic patients remain underrepresented in cancer clinical trials, but in recent years their participation has increased. In a study of 766 cancer trials involving nearly a quarter of a million participants, Juan F. Javier-DesLoges (above) of UC San Diego and his colleagues found that Black and Hispanic subjects were involved in breast cancer

Blacks and Hispanics under-represented in colorectal cancer trials Read More »

Blacks and Hispanics under-represented in lung cancer trials

Black and Hispanic patients remain underrepresented in cancer clinical trials, but in recent years their participation has increased. In a study of 766 cancer trials involving nearly a quarter of a million participants, Juan F. Javier-DesLoges (above) of UC San Diego and his colleagues found that Black and Hispanic subjects were involved in breast cancer

Blacks and Hispanics under-represented in lung cancer trials Read More »

Blacks and Hispanics under-represented in prostate cancer trials

Black and Hispanic patients remain underrepresented in cancer clinical trials, but in recent years their participation has increased. In a study of 766 cancer trials involving nearly a quarter of a million participants, Juan F. Javier-DesLoges (above) of UC San Diego and his colleagues found that Black and Hispanic subjects were involved in breast cancer

Blacks and Hispanics under-represented in prostate cancer trials Read More »

Scroll to Top